Virtual Recall's products include vaccination, neutering, appointment and healthcheck reminders, customer feedback, telemedicine and post operation surveys, and healthcare advice communications.
Jamie Brannan, Senior Vice President UK, Ireland and Nordics said: "This is an exciting opportunity for Zoetis to add a new solution for veterinarians with an innovative service that will support clinics in increasing their level of compliance, education and engagement at the pet owner level.
"As we expand our comprehensive offering across the continuum of care for veterinary clinics, Virtual Recall will enhance the level of pet owner services that can be offered to their pet owner customers in the UK, Australia and New Zealand.
“Our studies have shown that veterinary customers are keen to reduce administrative workload and find new ways to engage with pet owners. We believe that Virtual Recall will achieve that, helping to educate and improve pet owner compliance and adding financial benefits to the veterinary practice.”
Jamie Crittall, Co-founder, Virtual Recall said: “As a company we’ve always been restless – constantly looking at new ways and developing new technologies in which we can drive animal healthcare compliance. Zoetis’ thoroughly well-earned reputation for always putting their customers first – wanting them to thrive and be successful – combined with a commitment to enhance the lives of people and animals, is infectious. It is a very exciting new chapter for Virtual Recall and fellow co-founder Charlie Barton and I are thrilled to continue at the helm."
The web based app, which has been launched in association with the BSAVA, provides a library of medical summaries drawn from global guidelines and peer-reviewed journals.
Vet2Vet co-founder Dr Zoe Coker said “There is rarely time during the working day to read all the necessary journals, articles and up-to-date texts. VETbytes collates all the evidence on a specific medical condition and consolidates it into a short synopsis called a Keep it Simple Summary (KISS)."
BSAVA President Professor Ian Ramsey said: “BSAVA is excited and proud to be involved in the VETbytes project, which should provide significant benefits and support for our members. Every busy small animal clinician should try out VETbytes as it is a real paradigm shift in mobile resources for vets.”
The VETbytes app currently covers more than 100 topics developed in consultation with more than 25 veterinary experts. Further benefits include drug (and CRI) calculators, a quick reference section and links to hundreds of source abstracts. The content encourages reflective learning and can be used towards CPD hours.
VETBytes is available on subscription with reduced rates for BSAVA members and free access for veterinary students.
To start a free trial or subscribe to the VETbytes app, visit www.vetbytes.co.uk.
Advance25 Courses provide 25 hours of CPD in important areas of small animal practice, including Small Animal Medicine Cases Challenges, Emergency Medicine, Abdominal Ultrasound and Thoracic and Abdominal Radiology.
Advance25 courses run for a 6 week period, with tutor support. Recorded and live sessions are combined with discussion of multiple cases. Course materials are then accessible for 12 months.
Susie Coughlan, Managing Director of CPD Solutions said: "We appreciate that there is a high demand for quality online options at the moment, with many vets limited to online CPD.
"With the new Advance25 courses we’ve added more tutor support and ongoing interaction for those who are looking for a more immersive experience providing extended CPD hours. We’re really excited about these courses, which are launching now and running in the autumn. They should help vets make a real difference in their practices; they’re fully flexible and will fit with many people’s family and work commitments.’
For more information and to enter a prize draw to win a free Advance25 course, visit: https://www.cpd-solutions.com/advance25
The Ear Protector sits on the back of the head and hooks onto face mask strings, pulling them backwards and away from the ears, thereby relieving pressure and stopping chafing.
The product was designed by AMufacture's Chief Operating Officer, William Howden, a former Olympic sailor who competed in the 2008 Summer Olympics in Beijing. He said: "Early in the pandemic, it became apparent to us that there was a serious need to address an unresolved problem with face masks – people were really beginning to suffer and were getting distracted from their work."
The Ear Protector is sterilisable in a dishwasher. It is also recyclable when it reaches the end of its life.
The Ear Protectors cost fifty pence each, for orders of two hundred. Contact the company direct for lower volume pricing.
For more information, visit: http://www.theearprotector.com
For the study, titled “RHDV2 epidemic in UK pet rabbits. Part 1: clinical features, gross post mortem and histopathological findings”1, veterinary surgeons were encouraged to submit case histories and the results of post mortem examinations of pet rabbits that died suddenly. Samples taken during the post mortem were sent for histopathological examination.
Frances Harcourt-Brown, corresponding author for the paper, said: "Case histories, macroscopic findings and histopathology results were available from 300 rabbits that died suddenly.
"Of these, 185 (62%) died from RHD and showed characteristic histopathological features of RHD including apoptosis and variable lytic and coagulative hepatocellular necrosis, with varying distribution.
"Interestingly, macroscopic evidence of disease was not present in all cases – for example, gross liver abnormalities were only reported in 30% of cases, despite all cases showing hepatocellular necrosis on microscopic examination.
"Rapid death and death of other rabbits in the household were common features of RHD.
"Histopathology was also useful in yielding valuable information about other causes of death in the rabbits that did not die from RHD.”
Nicola Di Girolamo, editor of JSAP said: “This is a terrible disease that is currently spreading in areas of the world that were free from it until recently. Having more evidence on the type of clinical presentations and lesions that should be expected with this disease in rabbit patients is going to be of tremendous value for clinicians. Given that there is not always macroscopic evidence of RHD, histopathology is key for the diagnosis of RHD in pet rabbits.”
The full article can be found in the July issue of the Journal of Small Animal Practice which is free for BSAVA members.
It can also be read online here: https://www.onlinelibrary.wiley.com/doi/full/10.1111/jsap.13141
Reference
Photo: BSAVA
Lax-a-Past is a palatable paste that can be administered orally to kittens and cats aged over 6 months.
It can be used weekly to help stop hairballs from forming or in higher doses over a consecutive three-day period to help eliminate them.
Carol Morgan, Brand Manager from Dechra Veterinary Products (pictured right) said: “Hairballs are a well-known issue for cats. Lax-a-Past is a complementary feed that offers a simple, easy-to-administer solution to help relieve the digestion problems caused by hairballs.
“It is very easy for owners to administer as the required dosage can be squeezed out and spread on a front paw or given directly into the mouth."
Lax-a-Past is available in a 70g tube.
For more information visit www.dechra.co.uk.
Christine said: "Tests conducted by the Animal and Plant Health Agency have confirmed that the virus responsible for COVID-19 has been detected in a pet cat in England.
"This is a very rare event with infected animals detected to date only showing mild clinical signs and recovering within in a few days.
"There is no evidence to suggest that pets directly transmit the virus to humans. We will continue to monitor this situation closely and will update our guidance to pet owners should the situation change."
Yvonne Doyle, Medical Director at Public Health England, said: "This is the first case of a domestic cat testing positive for COVID-19 in the UK but should not be a cause for alarm.
"The investigation into this case suggest that the infection was spread from humans to animal, and not the other way round. At this time, there is no evidence that pets can transmit the disease to humans.
The pet cat was initially diagnosed by a vet with feline herpes virus, but the sample was also tested for SARS-CoV-2 as part of a research programme at the Centre for Virus Research at Glasgow University. Follow-up samples tested at the APHA laboratory in Weybridge confirmed the cat was also co-infected with SARS-CoV2 , the virus known to cause COVID-19 in humans.
BSAVA advice for practising vets about coronavirus is here and further information about testing is available here.
APPA is an oral, patented, fixed-dose combination of two synthetic secondary metabolites of plant origin, apocynin and paenol.
Under the terms of the agreement, AKL’s unnamed partner will fund a study in dogs with naturally occurring OA. The study will compare the efficacy and efficacy duration of APPA with the current standard of care for treating canine OA: non-steroidal anti-inflammatory drugs.
David Miles, AKLRD CEO, said: “Just like humans, millions of dogs suffer intolerable pain and disability because of OA and the current treatments just aren’t as effective or as well tolerated as they need to be. We already know from previous canine studies that APPA reduces pain and has an excellent tolerability profile but this exciting new partnership will allow us to go one stage further and assess sustainability of response.”
The randomised study will assess pain and duration of response as the primary endpoint. Secondary endpoint assessment will include adverse events, quality of life, pharmacokinetics analysis and biomarkers that may enable potential identification of factors predictive of response at treatment onset, or that correlate with response magnitude.
Two separate studies on dogs have already been carried out by researchers at the University of Vienna. The first, an 11-week cross-over study of 32 canines diagnosed with established, naturally occurring OA, showed that APPA provides significant symptom relief in clinical canine OA1.
A follow-up, five-week study of 60 dogs with OA compared APPA to the standard of care drug, meloxicam. It concluded that daily oral administration of APPA was effective as a stand-alone alternative to NSAIDs in dogs with naturally occurring OA. Significant benefits were also seen for APPA over meloxicam in orthopaedic examination as well as in lameness and function scores2.
The results will inform the pivotal clinical trial design and AKL says its working assumption is that a 26-week field study would complete the regulatory requirements for commercialisation.
If the study and future testing is successful, AKL estimates that APPA would be well placed to capture a significant share of the global canine OA market, which is estimated to be worth $3billion by 20283.
References
For the research, 2000 pet owners were asked whether they they had bought counterfeit pet medicines online. 31.3% said yes. They were then asked if they had reported the matter. 62.2% said they had. Finally, they were asked what the outcome of their report was. 60.9% said their purchase was confirmed as a fake, suggesting that at least one in ten pet owners - probably more - have bought fake pet medicines.
Bayer says the true number of owners affected is likely to be even higher, as a further 12% of pet owners in the survey said they believed that they may have bought fake pet medicines but had not reported it.
The research also showed that 87% of shoppers purchased pet parasite prevention products from unaccredited sites that have been known to sell counterfeit pet medicines. Indeed since April this year, the VMD has removed over 500 veterinary medicine listings from online marketplaces.
The message to clients is that chasing the lowest price for veterinary medicines can be a false economy.
Photo: Can you tell whether this product is fake or not?
Tramvetol is presented in two pack sizes of 30 and 100 tablets to assist practices with dispensing and storage as a Schedule 3 controlled drug. The meat flavoured 50mg tablets can also be divided into two equal parts to ensure accurate dosing.
Virbac says Tramvetol is suitable for both short courses and long-term treatment; 2-4mg per kg of Tramvetol can be administered every 8 hours or from 6 hours, if required, based on the intensity of the pain. In addition, Tramvetol has a wide therapeutic window and a maximum daily dose of 16mg per kg.
Commonly used in combination with other forms of analgesia, including NSAIDs1, Tramvetol is quickly absorbed and boats a rapid onset of action2. Peak plasma concentrations are achieved within 45 minutes3.
Dan Johnson, Product Manager at Virbac said: ‘Tramadol is already an important part of the analgesia toolkit for many veterinary practices. We hope that Tramvetol will prove to be a much more convenient option for practices, whilst helping to provide dogs with a better quality, pain free life’.
For more information, contact your Virbac Territory Manager.
The BVA has partnered with Closer Still Media, the impresarios behind the London Vet Show, to organise the event. They say it will cater for 1,500 veterinary professionals and provide high-value, low-cost, practical clinical and non-clinical CPD, big issue debates, and showcase key veterinary suppliers and vendors in the exhibition in a vibrant central location.
BVA President Daniella Dos Santos said: "I’m delighted to announce the launch of BVA Live. It’s an opportunity for BVA to return to hosting our own standalone conference for the first time since BVA Congress became part of the London Vet Show in 2013. The new conference will enable the veterinary community to come together, outside of London, to develop and thrive through a programme of excellent CPD, delivered by world class speakers.
"For me the most important element of BVA Live is bringing the veterinary profession together to tackle the big issues we face and providing an opportunity to engage with BVA Officers, volunteers and staff in one central venue. By hosting the conference at the NEC, Birmingham, with its excellent direct road, rail and air links it means that we can provide a greater regional offering to the veterinary profession."
It remains to be seen what impact this new conference will have on BSAVA Congress, which for many years was pretty much the only gig in town. Then, with the London Vet Show snapping at its heels, it announced it would move north from Birmingham to Manchester from 2021. Hardly will the dust have settled, than BVA and CloserStill are filling the void. At this rate, BSAVA Congress will probably have to move to the Hebrides by 2025.
It looks like there are a lot of dice being rolled here. Will more vets want to meet in Manchester than Birmingham? Will any of us be meeting next year, or will coronavirus continue to limit gatherings in 2021?
For more information and to register your interest in attending, visit bvalive.vetshow.com
Stelfonta is licensed for the treatment of non-resectable, non-metastatic (WHO staging1) subcutaneous mast cell tumours (MCTs) located at or distal to the elbow or the hock, and non-resectable, non-metastatic cutaneous MCTs in dogs. Tumours must be less than or equal to 8cm3 in volume and must be accessible to intratumoural injection.
The company says that a single intratumoural treatment has been seen to destroy the tumour completely in 75% of observed cases.
The active ingredient in Stelfonta is tigilanol tiglate, a compound extracted from Fontainea picrosperma, a shrub found in the Australian rain forest. According to the company, it works largely through specific protein kinase c (PKC) activation, in which it locally stimulates the immune system, resulting in destruction of the tumour and the tumour’s blood supply, followed by rapid healing of the site with minimal scarring.
Virbac says that generally, dogs do not require sedation or local or general anaesthesia during treatment.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Stelfonta is an innovative yet simple treatment which provides a high tumour elimination rate, rapid healing and a speedy return to a good quality of life for the pet. In the cases studied, the tumour was destroyed in seven days and full wound healing observed in 96.5% of cases, with no significant adverse effects on the dog.
“The effects of Stelfonta really do need to be seen to be believed."
The service has been free of charge since March 15th 2020, when it first became clear how difficult things would become. However, as life has become less restricted, now seemed an appropriate time to introduce a very modest charge to help with the site's ongoing development and maintenance.
Over the last four and a half months, there has been a significant increase in the number of jobs advertised on VetSurgeon (to the extent that VetSurgeon and VetNurse Jobs now have more jobs advertised than either the Veterinary Times or the Veterinary Record). What's more, feedback from advertisers is that they've received more enquiries both on VetSurgeon.org and over on VetNurse Jobs.
On VetSurgeon, this may be due in part to a number of locum vets seeking permanent positions. However, it also seems likely to be a consequence of a 'virtuous circle' whereby more jobs advertised = more visibility on Google and other social networks = more enquiries = more jobs advertised = more visibility and so on.
For this reason, the plan for the future is to optimise the price of advertising on VetSurgeon.org at the lowest level needed to encourage the largest number of vacancies, the greatest number of enquiries and the revenue needed to pay for the ongoing running of the sites.
For more information about recruitment advertising on VetSurgeon.org.
The most recent case of rabies in a bat in Great Britain was in July 2020 in Wimbourne, Dorset and there were four cases in 2019.
Like many wild animals, bats can carry a number of different pathogens, including European Bat Lyssaviruses (EBLVs) 1 and 2 – also referred to as bat rabies. The rabies virus is present in the saliva of infected bats and is usually spread to humans or other mammals by the bite of an infected bat. The virus may also enter the body via open wounds or mucous membranes.
The BSAVA says that whilst the risk of transmission to humans is considered low, those handling bats may be at an increased risk of contracting the disease and those who regularly handle bats should be vaccinated against rabies.
Those who are not vaccinated against the disease should assume that all bats are possible carriers of rabies. Individuals handling bats should wear gloves of a suitable thickness for the species of bat they are handling to avoid being bitten or scratched. Further information on how to safely contain and handle a bat can be found on the Bat Conservation Trust website.
In the event that an individual is bitten or scratched by a bat or exposed to bat saliva or nervous tissue in any other way, they should seek immediate medical advice. The contact area should be washed with soap and water, and any wounds must be disinfected. Further information can be found on the APHA, PHE and NHS websites.
In 2008, a case involving an injured bat carrying EBLV type 2 was treated by a vet and her staff, who were unaware of the potential of rabies risk from bats. The bat handlers had previously been vaccinated as recommended by the Department of Health but despite sustaining a needlestick injury during surgery, the vet and her staff had neither sought nor received post-exposure prophylaxis.1
Professor Ian Ramsey, president of the BSAVA, said: “Although this case was 12 years ago it is a pertinent reminder of why we need to be well-prepared when handling bats. Whilst the risk of human rabies infection from bats is low, the publication of the new statistics show that EBLVs are circulating in a small number of wild bats. Injured bats are often presented to small animal vets, so we have taken this opportunity to remind our members and others of the potential risks of rabies transmission, and how to mitigate against these.
"For more advice on the handling and treatment of wildlife casualties including bats, we advise vets to consult a reference book such as the BSAVA Manual of Wildlife Casualties."
The series looks in detail at some of the most important issues dental specialists are seeing in pets.
The first webinar in the series, which is going live on Tuesday 3rd November at 8:00pm, looks at the impact periodontal disease has on both cats and dogs.
Co-speaker and veterinary dental specialist, Jens Ruhnau DVM, DEVDC (above, left) discusses the importance of understanding and treating the condition: "Research has shown that over 80% of dogs over the age of three, and the majority of cats, are impacted by periodontal disease. Treating the disease early and correctly is key to reducing further spread, secondary infection, and ultimately improving the quality of life of the animal".
The second webinar in the series, which will be live on Tuesday 10th November at 8:00pm, shares advice on treating tooth fractures in pets. Looking at tips on how to perform an effective oral examination, along with reviewing recent studies on the fracture limits of teeth in pet dogs.
Co-speaker and founder of DentalVets, Norman Johnston (above, right) said: "Tooth fractures are very common in both cats and dogs, and can be caused by a variety of reasons. Looking in more detail at the diagnostic process, treatments options and being aware of what objects can cause damage will help veterinary professionals, and in-turn owners, understand more about the risk of fractures."
Both webinars are free to attend, to find out more information and to register click here. https://www.thewebinarvet.com/pages/mars-petcare-free-webinars-tooth-fractures-periodontal-disease
Equipalazone is most commonly used to treat lameness in equines and can be prescribed as a treatment for osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis as well as to reduce post-surgical soft tissue reaction.
The new apple-flavoured version, which contains no added sugar, is presented in 1.5g sachets which are added to feed. The existing unflavoured product is still available as Equipalazone Original.
Dechra Brand Manager Emma Jennings said: “The new apple flavoured Equipalazone is the same tried and trusted popular product that vets have been using for many years but the enhanced apple flavour should improve compliance amongst even the fussiest of feeders.
"Equipalazone has been a best-selling treatment delivering powerful pain relief since we brought it to the market as the first microencapsulated phenylbutazone more than 45 years ago. The new apple flavoured presentation will give vets even more choice when it comes to providing pain relief and anti-inflammatory treatment for equine conditions."
The company highlights figures which show that about 170,000 of calves born alive each year die in their first month of life1 and that up to 50% of deaths are caused by scour2, with over 48% of dairy heifer calves diagnosed with scour preweaning3. ORT, says the company, could help save the industry £60 million a year1.
The new campaign will encourage farmers to use ORT during scouring to provide sufficient essential electrolytes to correct acidosis, while still continuing with milk feeding. The company says milk is the best source of energy and fluid replacement for scouring calves and stopping milk has been shown to have no impact on the resolution of scour. In fact, calves left on milk during scour can continue to gain weight. The Making Milk Matter Against Scour initiative is being backed by a PR and advertising campaign and a social media initiative.
During the campaign Ceva will be running surveys to capture both vets’ and farmers’ experiences of scour and ORT. To take part in the vet survey visit https://www.surveymonkey.co.uk/r/ORTVet. There will be a prize draw from completed entries, with 10 vets receiving a £10 Amazon voucher.
Stephenie Clarke, product manager at Ceva Animal Health said: "The ‘Making Milk Matter Against Scour’ campaign will help highlight the financial and welfare benefits of using ORT at the first signs of scour and the importance of administering it alongside milk which is the best source of energy and will help calves maintain weight gain.
"The scour survey will provide us with an insight into the use of ORT in practice and on farm to help us drive improvements across the industry."
James Adams, BVSc FHEA MRCVS, farm animal lead at Langford Vets, University of Bristol, added: “If I could offer one piece of advice to farmers with scouring animals it would be to ensure hydration as dehydration is what kills! Rehydrating an animal is essential if an animal is to be able to regain its normal function and fend off any disease.
"We’ve been using Rehydion in our vet practice for approximately two years and we mainly recommend that farmers use it in cattle, but our clients also use it in lambs and kids. We get a lot of positive feedback from farmers on Rehydion, as they feel that it is effective and convenient to use, which aids compliance, and it can be given with milk, which is essential for maintaining a positive energy status."
For further information on the ‘Making Milk Matter Against Scour’ initiative visit www.makingmilkmatter.co.uk, contact your local Ceva Account Manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
For the survey, 565 respondents ranked their levels of concern about different aspects of veterinary life that may be affected by coronavirus.
The top concerns were:
In addition, 42% were very or quite concerned about contracting Covid-19 in their workplace, rising to 55% amongst those working in mixed practice and 50% in small animal/exotic practice.
Respondents were more concerned about stress and burnout amongst their colleagues (67% very or quite concerned) than the impact on themselves (45%), but more than half (58%) of small animal/exotics vets reported being concerned about their own stress and burnout. Managers and employees reported higher levels of concern around stress and burnout than business owners and those who are self-employed.
When it comes to employment, the profession is a bit more optimistic. 23% of respondents are not at all concerned about job security in the veterinary sector, with 43% a little concerned and 31% very or quite concerned. Equine vets (45%) and charity vets (64%) are very or quite concerned about job security in their own sectors, against an average of 23% across all areas of work.
However, 95% of respondents had some level of concern (a little, quite or very) about the potential impact of a recession on the veterinary sector, with government, equine and charity vets most concerned.
The findings will be used to inform BVA’s work on supporting the veterinary profession as the pandemic continues.
BVA President James Russell said: “Although this is just a snapshot survey, it tells us a lot about how our colleagues are feeling six months on from the national lockdown. It paints a worrying, but not surprising, picture about the health and wellbeing of a profession that has worked incredibly hard and in very difficult circumstances this year.
“I’m incredibly proud of the way the profession has adapted to working safely during Covid-19, but we know that it has taken its toll, for example with consults taking longer, needing to cover staff shortages, and dealing with anxious clients.
“BVA also shares the profession’s concerns about the impact on students and new graduates. EMS is the jewel in the crown of UK veterinary teaching and it’s frustrating that opportunities to gain practical training have been hampered by the Covid restrictions. The issue is at the top of our agenda with the RCVS and Vet Schools Council to make sure we can collectively support the next generation of vets through this difficult time.
“As the UK is braced for the second wave, we know we are much better prepared and far more able to work safely to do our bit to tackle the spread of coronavirus. But it’s vital that we continue to support one another, as well as continuing the spirit of collaboration with neighbouring practices that helped us get through the height of the pandemic.
The snapshot survey on Covid-19 is available to view at: https://www.bva.co.uk/media/3781/voice-covid-survey-2020-results.pdf
Julia, who is a leading exponent of the Brainstem Auditory Evoked Response (BAER) screening test, will also support the small animal referral hospital’s neurology, ophthalmology and dermatology teams with enhanced diagnostics.
Julia was a neurology technician at the Animal Health Trust for 31 years, until it closed in July 2020. With colleagues there she helped to develop and implement BAER testing as a screening process in animals at risk of congenital deafness. Davies says this is now recognised as the gold standard in deafness testing by organisations such as The Kennel Club and various breed clubs in the UK.
Julia said: “I am so happy to be starting a new chapter at Davies. It is really exciting to be establishing the Hearing Assessment Clinic here and continuing to provide this important service both to previous clients and new ones. I am also looking forward to developing a successful, constructive working relationship with my new colleagues."
Tim Richardson, Managing Director of Davies said: "We are delighted to welcome Julia to the team at Davies. As one of the UK’s leaders in this highly specialised field she enables us to offer hearing screening, hearing tests and electrodiagnostics across the relevant disciplines, at the very highest level."
For further information visit www.vetspecialists.co.uk
Sioned Timothy, Ruminant Technical Manager at Boehringer said: "The financial and production impact of liver fluke should not be underestimated. Recent abattoir research in Ireland, published this year, has shown that a fattening steer with fluke infection will put on 36kg less live weight gain over its lifetime versus a healthy steer, costing the producer around £63, per animal.
"Additionally, analysis of data from cattle at a Scottish abattoir showed that animals with 1 to 10 liver fluke present in their liver took an average 31 days longer to reach slaughter weight, while animals with more than 10 liver fluke present took an additional 77 days longer to reach slaughter weight versus animals without any liver fluke infection2.
"Liver fluke infections can also lead to hormonal and metabolic imbalances, affecting reproduction in female animals and extending breeding targets3. Affected animals may also be more susceptible to secondary bacterial infections, such as Salmonella and Clostridial infections3."
Boehringer says that with cattle being brought in for winter housing, now is an ideal opportunity to remove productivity-limiting parasites that were acquired during the grazing season. The main targets for parasite control at this time of year are gutworms, lungworm and liver fluke, however the specific risk will vary from farm to farm.
The company adds that the choice of treatment for liver fluke at housing is complicated by emerging resistance to triclabendazole. This is the only flukicide that treats the early immature stage of liver fluke, responsible for acute disease in sheep but not of clinical relevance in cattle.
Sioned said: "Prescribing an alternative flukicide for cattle at housing will reduce selection for resistance and, by targeting the later stages of the parasite, control the impact of liver fluke on productivity.
"Flukicides containing clorsulon (contained in Ivomec Super) will remove the adult stages of fluke in cattle, while those containing closantel, or nitroxynil (the active ingredient of Trodax), are effective against both late immature and adult stages.
"To ensure that cattle have no residual fluke burden, they may need to be re-treated at an appropriate interval after the initial housing dose. Diagnostic testing can be used to determine whether a second treatment is necessary. This approach will ensure that cattle are turned back out onto pasture fluke free."
For the study, 2,834 seizure incident cases were identified from a population of 455,553 dogs attending VetCompass participating practices in 2013.
The study found that that approximately 1 in 160 dogs under first opinion veterinary care are affected by seizures every year.
Many of those dogs will have underlying epilepsy, defined as dogs with two or more unprovoked seizures at least 24 hours apart. Seizures can be secondary to idiopathic epilepsy, structural epilepsy or epilepsy of unknown cause.
Until now, however, there has been little information on the classifications of seizures, diagnostic approaches, or clinical management of dogs with seizures in the veterinary first opinion population.
The main findings from the research were:
Dr Dan O’Neill, Senior Lecturer in Companion Animals Epidemiology at the RVC, and author of the paper, said: "Watching your dog undergo a seizure can be an incredibly scary moment for any dog owner. It is really important that dogs that seizure are rapidly diagnosed to decide whether they need no further treatment beyond careful monitoring or alternatively require a clinical work-up to define the cause of the seizures.
"There are now some excellent treatments for many seizure-related diseases. This study helps up to understand the current state of play for seizure management in dogs and identifies opportunities for improved care of these affected dogs."
The full paper is freely available from Journal of Veterinary Internal Medicine and can be accessed here: https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.15911
The company has created a waiting room board kit, social media pack and a video which surgeries can play on waiting room televisions.
The board kit comprises cut out images of items which are commonly found in a typical Christmas shopping basket which can be toxic or dangerous to pets. Meanwhile, the video explains the dangers pet owners need to be aware of throughout the year.
For practices which are limiting the number of people coming into the premises, TVM is also offering waterproof posters which can be displayed outside surgeries, along with Pet Dangers leaflets for clients to take home.
Will Peel, Product Manager of TVM UK, said: ‘We know that poisoning cases increase significantly over the Christmas period and while many pet owners are aware of the items which are toxic to their pets, it’s easy to get distracted during the festive season so the materials we have put together are intended as a reminder to be diligent and keep pets safe from harm.’
To claim your free Pet Dangers practice resource kit, visit https://www.tvm-uk.com/order-your-tvm-uk-christmas-pet-dangers-display-kit, contact your local territory manager, email help@tvm-uk.com or call 0800 0385868.
Generally, veterinary practices may remain open, but there are national variations in what services should be offered and how, including the conditions under which remote prescribing can be used to help support a case.
Wales currently has the tightest ‘firebreak’ restrictions, meaning practices can only provide essential and urgent work until midnight on 8 November 2020, thereafter, returning to usual operations in line with Wales’ standard measures around workplace safety.
England and Northern Ireland are under national restrictions (4 Nov – 2 Dec, and 16 Oct – 12 Nov, respectively), meaning practices can provide treatment essential for maintaining animal health and welfare, along with non-urgent work providing that social distancing measures and safe working can be maintained.
Veterinary surgeons practising in these three countries may also choose to support a case remotely at an earlier stage, for example, through the remote prescribing of POM-Vs without first having conducted a physical examination.
Scotland remains the only country under regional tiered restrictions, meaning practices can continue to provide treatment whilst maintaining social distancing; however, before remote prescribing is offered, veterinary surgeons should first consider whether the animal can be brought under their care.
The full guidance and corresponding flowcharts should be consulted together and are available at www.rcvs.org.uk/covidfaq2and www.rcvs.org.uk/covidfaq4.
The College has confirmed that it has now received an official complaint about the matter and it is now investigating under its normal 'concerns' investigation process.
Professor Argyle made a private statement about the allegations to RCVS Council at its meeting today, having already answered written questions from a number of Council members in the preceding days.
The Council did not ask Professor Argyle to step aside, but acknowledged that this was his choice, made for personal reasons.
The College said that in line with its normal protocols, and to ensure fairness for all parties, it will not make any further public comment about the investigation for the time being. However, it wanted to stress that it remains firmly committed to following due and proper process in all its regulatory activities.
In the video, VetSurgeon.org Editor Arlo Guthrie explains how the site has been developed to overcome various problems with using Facebook for clinical discussion.
One of the biggest problems with Facebook is that it lends itself to large number of short-form quick-fire replies which are often repetitive and can bury any really useful pearls of wisdom. Another issue is that on Facebook, everyone's post is given a misleading equivalence. In other words, it doesn't matter whether you're the leading veterinary cardiologist in the country or someone who left vet school last week, your opinion is given the same prominence. That's misleading.
The VetSurgeon.org discussion platform lends itself to longer, more thoughtful replies, and expert opinion is elevated above the rest. Information is curated by subject area and, using the Claim CPD button, easy to bookmark and refer back to later.
In the VetSurgeon Expert Help Forums, any member can post a question but only experts (those with referral practitioner, academia or industry membership categories) can reply. When you thank the experts for their help, their logo and contact details are embedded within their answer. This overcomes another problem with less tightly-controlled discussion formats, which is that they can occasionally get quite nasty. Aside from the fact that the experts are a fantastically nice and helpful bunch of people, who on earth wants their logo attached to anything less than helpful!
None of this is to say that Facebook doesn't have its place. The large volume of short-form replies make it a great place for non clinical discussion, such as veterinary politics and general banter.
However, when it comes to clinical discussion and information-sharing, VetSurgeon.org sets the standard.
If you agree with the points raise in the video, do press the 'Like' button on YouTube and share it with colleagues.